Compare Abbott Laboratories (ABT) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Motorola Solutions Inc — how do they compare? Abbott Laboratories trades at $95.13 (market cap $166.94B), while Motorola Solutions Inc trades at $421.22 (market cap $70.42B). The key difference: Abbott Laboratories is far larger — about 2.4× Motorola Solutions Inc's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | MSI | |
|---|---|---|
Market Cap | $166.94B | $70.42B |
Sector | Health | Technology |
52-Week High | $136.62 | $490.30 |
52-Week Low | $82.57 | $363.83 |
Enterprise Value | $193.69B | $79.12B |
Dividend Yield | 2.63% | 1.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Motorola Solutions (MSI) trades at $424.21, up 0.37% with strong technical momentum and bullish analyst sentiment. The company demonstrates robust fundamentals with 17.61% net margins and consistent earnings beats, supported by recent AI expansion initiatives and a $1.5B acquisition of D-Fend Solutions. Revenue growth has accelerated from $9.1B in 2022 to $11.7B in 2025.
MSI presents a compelling growth story with AI-driven public safety expansion and strong institutional support, though elevated valuation multiples and increased capital expenditures pose risks. The consensus price target of $512.33 suggests 21% upside potential, supported by 71% analyst buy ratings and positive technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
